CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein

Vaccine

Volumn 20, Issue 31-32, 2002, Pages 3731-3738

  Gschoesser, C ^a   Almanzar, G ^a   Hainz, U ^a   Ortin, J ^b   Schonitzer, D ^c   Schild, H ^d   Saurwein Teissl, M ^a   Grubeck Loebenstein, B ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aging; CD4+ cells; CD8+ cells; Influenza; Influenza nucleoprotein; Influenza vaccination; Recombinant proteins; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INFLUENZA NUCLEOPROTEIN; INFLUENZA VACCINE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; CORE PROTEIN; LIVE VACCINE; NP PROTEIN, INFLUENZA A VIRUS; NUCLEOPROTEIN; RECOMBINANT VACCINE; RNA BINDING PROTEIN;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; INFLUENZA VACCINATION; INFLUENZA VIRUS; LYMPHOCYTE CULTURE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; AGING; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; CELL SEPARATION; COMPARATIVE STUDY; DRUG EFFECT; IMMUNOLOGY; INFLUENZA VIRUS A; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; ANTIGENS, CD8; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL SEPARATION; CELLS, CULTURED; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS; INFLUENZA VACCINES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; NUCLEOPROTEINS; RECOMBINANT PROTEINS; RNA-BINDING PROTEINS; T-LYMPHOCYTE SUBSETS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL CORE PROTEINS;

EID: 0036839467     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00355-9     Document Type: Article

References (40)

1. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin. Infect. Dis. 31(2):2000;578-585.
2. Webster R.G. Immunity to influenza in the elderly. Vaccine. 18(16):2000;1686-1689.
3. Bridges C.B., Fukuda K., Cox N.J., Singleton J.A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 50(RR-4):2001;1-44.
4. Piedra P.A. Influenza virus pneumonia: pathogenesis, treatment, and prevention. Semin. Respir. Infect. 10(4):1995;216-223.
5. De Jong J.C., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D. Influenza virus: a master of metamorphosis. J. Infect. 40(3):2000;218-228.
6. Scholtissek C. Molecular epidemiology of influenza. Arch. Virol. Suppl. 13:1997;99-103.
7. Kendal A.P. Epidemiologic implications of changes in the influenza virus genome. Am. J. Med. 82(6A):1987;4-14.
8. Scholtissek C., Ludwig S., Fitch W.M. Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages. Arch. Virol. 131(3/4):1993;237-250.
9. Shu L.L., Bean W.J., Webster R.G. Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990. J. Virol. 67(5):1993;2723-2729.
10. Briedis D.J., Tobin M. Influenza B virus genome: complete nucleotide sequence of the influenza B/lee/40 virus genome RNA segment 5 encoding the nucleoprotein and comparison with the B/Singapore/222/79 nucleoprotein. Virology. 133(2):1984;448-455.
11. + memory T cells by viral variants. J. Exp. Med. 190(9):1999;1319-1328.
12. Beyer W.E., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7(5):1989;385-394.
13. Bernstein E., Kaye D., Abrutyn E., Gross P., Dorfman M., Murasko D.M. Immune response to influenza vaccination in a large healthy elderly population. Vaccine. 17(1):1999;82-94.
14. Powers D.C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J. Med. Virol. 43(1):1994;57-61.
15. Prasad S.A., Norbury C.C., Chen W., Bennink J.R., Yewdell J.W. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to non-immune cells. J. Immunol. 166(8):2001;4809-4812.
16. + T cell cross-priming with exogenous antigens. J. Immunol. 166(12):2001;7268-7275.
17. + T cells in vivo. J. Immunol. 166(7):2001;4355-4362.
18. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17(3):1996;131-137.
19. Carbone F.R., Kurts C., Bennett S.R., Miller J.F., Heath W.R. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today. 19(8):1998;368-373.
20. Gooding L.R., Edwards C.B. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J. Immunol. 124(3):1980;1258-1262.
21. Bevan M.J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117(6):1976;2233-2238.
22. Mock D.J., Roberts N.J. Jr. Role of the monocyte-macrophage in influenza virus infection of lymphocytes: implications for HIV infection. AIDS Res. Hum. Retroviruses. 6(8):1990;965-966.
23. Stein-Streilein J., Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136(4):1986;1435-1441.
24. Virelizier J.L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J. Immunol. 115(2):1975;434-439.
25. Zambon M.C. Epidemiology and pathogenesis of influenza. J. Antimicrob. Chemother. 44(Suppl. B):1999;3-9.
26. McMichael A.J., Askonas B.A. Influenza virus-specific cytotoxic T cells in man: induction and properties of the cytotoxic cell. Eur. J. Immunol. 8(10):1978;705-711.
27. Rimmelzwaan G.F., Osterhaus A.D. Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine. 13(8):1995;703-705.
28. + T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167(6):2001;3293-3299.
29. Norris M.S., McConnell T.J., Mannie M.D. Interleukin-2 promotes antigenic reactivity of rested T cells but prolongs the post-activational refractory phase of activated T cells. Cell Immunol. 211(1):2001;51-60.
30. Faulkner L., Buchan G., Lockhart E., Slobbe L., Wilson M., Baird M. IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. Int. Immunol. 13(6):2001;713-721.
31. + CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule. Vaccine. 17(4):1999;373-383.
32. Perillo N.L., Walford R.L., Newman M.A., Effros R.B. Human T lymphocytes possess a limited in vitro life span. Exp. Gerontol. 24(3):1989;177-187.
33. Pawelec G., Adibzadeh M., Rehbein A., Hahnel K., Wagner W., Engel A. In vitro senescence models for human T lymphocytes. Vaccine. 18(16):2000;1666-1674.
34. Effros R.B., Pawelec G. Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol. Today. 18(9):1997;450-454.
35. Pawelec G., Rehbein A., Haehnel K., Merl A., Adibzadeh M. Human T cell clones in long-term culture as a model of immunosenescence. Immunol. Rev. 160:1997;31-42.
36. Pawelec G., Effros R.B., Caruso C., Remarque E., Barnett Y., Solana R. T cells and aging (update February 1999). Front. Biosci. 4:1999;D216-D269.
37. Pawelec G. Hypothesis: loss of telomerase inducibility and subsequent replicative senescence in cultured human T cells is a result of altered co-stimulation. Mech. Ageing Dev. 121(1-3):2000;181-185.
38. Hayflick L. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621.
39. Tivol E.A., Schweitzer A.N., Sharpe A.H. Co-stimulation and autoimmunity. Curr. Opin. Immunol. 8(6):1996;822-830.
40. Kobata T., Azuma M., Yagita H., Okumura K. Role of co-stimulatory molecules in autoimmunity. Rev. Immunogenet. 2(1):2000;74-80.